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ABSTRACT
An adaptive response to alkylating agents based
upon the conformational change of a methylpho-
sphotriester (MPT) DNA repair protein to a transcrip-
tional activator has been demonstrated in a number
of bacterial species, but this mechanism appears
largely absent from eukaryotes. Here, we dem-
onstrate that the human pathogen Aspergillus
fumigatus elicits an adaptive response to sub-lethal
doses of the mono-functional alkylating agent
N-methyl-N0-nitro-N-nitrosoguanidine (MNNG). We
have identified genes that encode MPT and
O6-alkylguanine DNA alkyltransferase (AGT) DNA
repair proteins; deletions of either of these genes
abolish the adaptive response and sensitize
the organism to MNNG. In vitro DNA repair
assays confirm the ability of MPT and AGT to
repair methylphosphotriester and O6-methylguanine
lesions respectively. In eukaryotes, the MPT protein
is confined to a select group of fungal species,
some of which are major mammalian and plant
pathogens. The evolutionary origin of the adaptive
response is bacterial and rooted within the
Firmicutes phylum. Inter-kingdom horizontal gene
transfer between Firmicutes and Ascomycete an-
cestors introduced the adaptive response into the
Fungal kingdom. Our data constitute the first
detailed characterization of the molecular mechan-
ism of the adaptive response in a lower eukaryote
and has applications for development of novel
fungal therapeutics targeting this DNA repair
system.
INTRODUCTION
Aspergillus fumigatus (A. fumigatus) is responsible for a
range of devastating diseases in immunocompromised
individuals, and while the extent of disease depends
largely on the immune status of the host, mortality rates
are extremely high ranging between 50 and 85% (1).
Currently, several strategies are available for the treatment
of Aspergillus-related diseases. These include conventional
methods such as the use of antifungal drugs which usually
target either the fungal cell wall or cell membrane (2).
More recently, other avenues for antifungal development
have been explored such as inhibition of fungal natural
product and secondary metabolite biosynthesis (3).
Despite signiﬁcant advances in antifungal strategies,
many important challenges still remain, in particular the
emergence of resistance to most classes of antifungal drugs
(4). The availability of the complete genome sequence
for A. fumigatus creates an opportunity to investigate
previously uncharacterized pathways, which may be
fungal-speciﬁc, providing potential novel drug targets for
antifungal development (5). Our particular focus was the
identiﬁcation and characterization of pathogen-speciﬁc
DNA repair pathways and their potential as new fungal
targets for therapeutic intervention, particularly in the
context of cancer patients undergoing alkylating
chemotherapeutic treatment, who are amongst some
of the most at risk individuals for invasive aspergillosis
disease.
Mono-functional alkylating agents, such as N-
methyl-N-nitrosourea (MNU), N-methyl-N0-nitro-N-
nitrosoguanidine (MNNG) and the metabolically active
form of dimethylnitrosamine are efﬁcient mutagens and
carcinogens (6). Methylating agents can react with nucleo-
philic sites on DNA molecules (7) and while the majority
of evidence indicates that the principal mutagenic and
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toxic lesion that results is O6-methylguanine (O6meG) a
dozen other sites in DNA bases and the oxygen atoms in
the phosphodiester linkage are also targets, the latter
results in the formation of phosphotriesters.
Escherichia coli and some other prokaryotes respond to
DNA alkylation damage by the induction of an adaptive
response which increases resistance to the mutagenic and
toxic effects of subsequent doses of alkylating agents (8).
The E. coli ada gene is the key player in the adaptive
response, and this has been extensively studied over
the last 30 years (9,10). The Ada protein functions both
as a direct DNA repair protein and as a positive regulator
of the adaptive response. The C-terminal region of
the Ada protein removes methyl groups from O6meG
and also O4-methylthymine onto cysteine residue 321
(Cys-321) in a stoichiometric and auto-inactivating
process that reduces the toxic and mutagenic effects of
these lesions (6,11). The transcriptional regulator
function is mediated by the N-terminal domain of the
Ada protein (12) in which cysteine residue 38 (Cys-38)
stoichiometrically removes methyl groups from one of
the methylphosphotriesters generated in DNA by
MNNG. This converts the Ada protein into an active
transcriptional regulator (13) for genes involved in the
alkylation response pathway, namely alkB, alkA and
aidB and also ada itself (14,15). Furthermore, E. coli
possesses a constitutively expressed O6-alkylguanine
DNA alkyltransferase, encoded by the ogt gene, which
exhibits signiﬁcant sequence similarity to the C-terminus
of Ada but which is distinct from the adaptive
response (16).
Since the early investigations in E. coli, an adaptive
response to alkylating agents has been found to be
widespread throughout bacterial species (17). However,
no adaptive response exists in the lower eukaryote,
Saccharomyces cerevisiae (18,19). A gene encoding
O6-alkylguanine DNA alkyltransferase (AGT) activity
has been cloned from S. cerevisiae by functional comple-
mentation of an E. coli ada/ogt double mutant, and this
gene has been designated MGT1 (20). Deletion of MGT1
sensitizes S. cerevisaie to sacriﬁcing and mutagenesis
following exposure to alkylating agents. In agreement
with the lack of an adaptive response in S. cerevisiae,
MGT1 transcript levels were not increased in wild-type
S. cerevisiae in response to alkylation treatment (21).
However, the biological effects of alkylating agents are
largely unexplored in ﬁlamentous fungi. An improved
growth rate in the presence of MNNG was observed for
Aspergillus nidulans, following exposure to a sub-lethal
dose (22) and DNA methyltransferase activity was also
observed in extracts of this fungus (23,24). This activity
has been shown to be highly inducible by MNNG treat-
ment of A. nidulans, and effective in repairing O6meG
and methylphosphotriesters, hallmarks of an adaptive
response. To date, A. nidulans is the only eukaryotic
organism demonstrated to possess an adaptive response
to alklyating agents that may be equivalent to that
observed in bacteria. Although up-regulation of repair
processes have been reported in mammalian cells and
tissues, no such alkyl phosphotriester-mediated mechan-
ism has been reported, indeed there is no evidence for
an alkyl phosphotriester alkyltransferase in higher
eukaryotes.
We hypothesized that such DNA alkylation-damage
mediated adaptive responses may be more widespread
in the Fungal kingdom and may therefore constitute
potential novel therapeutic targets against fungal patho-
gens. We therefore assessed whether an adaptive response
to alkylating agents exists in the widespread and highly
pathogenic fungus A. fumigatus. We identiﬁed open
reading frames (ORFs) in this organism that were pre-
dicted to encode for an AGT and a methylphosphotriester
methyltransferase (MPT). We show that A. fumigatus does
possess an adaptive response to alkylating agents, and
that deletion of the genes encoding the AGT and the
MPT ablates this response in the fungus, concomitantly
increasing sensitivity to MNNG. We have characterized
the adaptive response at the transcriptional level and
demonstrated that the AGT and MPT proteins can
repair O6meG and methylphosphotriester (methylPT)
lesions, respectively. Functional conservation of AGT
activity is conﬁrmed by the ability of AfAGT to fully com-
plement the MNNG sensitivity of a S. cerevisiae mgt1
deletion strain. Furthermore, using phylogenetics we
identify the potential existence of an adaptive response
to alkylating agents in a number of Ascomycete fungi,
and we show that the bacterial adaptive response is
rooted in the ancient Firmicutes phylum.
These data demonstrate, for the ﬁrst time, that there is
an adaptive response to alkylating agents in the human
pathogen A. fumigatus. The lack of a corresponding
system in mammalian organisms, together with the
rise in invasive Aspergillus infections, and short-falls in
current treatment, make this response an attractive pos-
sibility as a novel drug target, warranting further
investigation.
MATERIALS AND METHODS
Strains, growth conditions and general DNA manipulation
The A. fumigatus Af293 strain was used in this study.
Fungal strains were grown in Aspergillus minimal media
(AMM), containing 1% (w/v) glucose as carbon-source,
5mM ammonium tartrate as nitrogen-source and trace
elements according to Pontecorvo et al. (25). Fungal
culturing was performed as previously described (26).
E. coli DH5a was used for general plasmid DNA propa-
gation and cultured in LB-AMP (containing 100 mg/ml)
for plasmid maintenance. A. fumigatus genomic DNA
was puriﬁed using a ZR Fungal/Bacterial DNA Kit
(Zymoresearch). S. cerevisiae strain used was BY4741
Dmgt1 derivative (Euroscarf).
Sequence data and database searches
E. coli protein sequences were obtained at NCBI (27).
BLAST searching was performed against Aspergillus
genomes and A. fumigatus genomic sequence data was
obtained from The Central Aspergillus Data Repository
(28). Amino acid sequences from all completely sequenced
prokaryotic genomes were obtained from the NCBI ftp
site (release 165). Our fungal data set consisted of 103
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fungal genomes. Where available, data was obtained from
the NCBI fungal genome FTP site (ftp://ftp.ncbi.nih.gov/
genomes/Fungi). The remaining data was downloaded
from the relevant sequencing centres [see Medina et al.
(29) for more information]. We also included 35 repre-
sentative non-fungal Eukaryotes in our database
(Supplementary Table S1). These were obtained from
the KEGG FTP site (http://www.kegg.jp/kegg/
download/). All sequence data was merged to produce a
local database. We also merged a subset of the genome
data to yield a separate, smaller representative database
(Supplementary Table S1).
Initially, Bacillus subtilis (strain 168) adaA (GenBank
accession P19219) and adaB (GenBank accession
P19220) proteins were used as query sequences against
the representative database. Taking one protein at a
time, gene families were located using the BlastP algo-
rithm (30) with a cut-off expectation (E) value of 1010.
Due to its patchy phyletic distribution a second database
search of adaA against the complete database was
performed. Homologous sequences were retrieved and
manually checked to ensure orthology.
Phylogenetic methods
Gene families were aligned using MUSCLE (v3.6) (31),
with the default settings. Phylogenetic relationships were
inferred using the maximum likelihood criterion.
Appropriate protein models of substitution were selected
using ModelGenerator (32). One hundred bootstrap rep-
licates were then carried out with the appropriate protein
model using the software program PHYML (33) and
summarized using the majority-rule consensus method.
RNA isolation and RT-PCR ampliﬁcation
Fungal RNA was isolated and puriﬁed from Aspergillus
hyphae crushed under liquid nitrogen using the
RNeasyTM plant mini kit (Qiagen). Prior to cDNA syn-
thesis, RNA was treated with DNase 1 (Invitrogen). RNA
quality was determined by visualization of intact 16S and
26S rRNA subunits by ethidium bromide staining
following agarose gel electrophoresis. cDNA synthesis
from RNA (500 ng) was performed using ﬁrst strand
transcription cDNA synthesis kit (Roche) with oligo
(dT) primers. The gene encoding calmodulin (calm)
which is constitutively expressed in A. fumigatus served
as a control in RT-PCR experiments (34).
Investigation of presence of adaptive response
Aspergillus fumigatus conidia (104) were used to inoculate
MEA agar plates with or without MNNG (0.5 mg/ml).
Following overnight growth, 0.5 cm2 plugs were taken
from these plates and transferred to fresh MEA plates
supplemented with increasing concentrations of MNNG
(0–4mg). Plates were incubated for a further 72 h, after
which the radial growth of the colonies was measured
and statistical analysis was performed by two-way
ANOVA. To investigate transcriptional activation of
genes in response to MNNG, A. fumigatus cultures
(n=9, 100ml each) were incubated at 37C. MNNG
(0.5 mg/ml) was added after 16 h to four of the cultures
(referred to as induced). One culture was harvested as an
uninduced reference at T=0h. Uninduced and induced
cultures were then harvested at 30min, 1 h, 2 h and 3 h
post-induction. RT-PCR was then performed for genes
of interest as described above.
Generation of A. fumigatus AFUA_5G06350 and
AFUA_2G02090 mutant strains
Aspergillus fumigatus transformation was carried out
according to Tilburn et al. (35). For generation of Afmpt
and Afagt mutant strains, the bipartite marker technique
was used (36), with modiﬁcations. Brieﬂy, A. fumigatus
Af293 was transformed with two DNA constructs, each
containing an incomplete fragment of a pyrithiamine
resistance gene (ptrA) (37,38), fused to 1.2 kb of 50- and
30-gene ﬂanking regions. The marker fragments shared a
557 bp overlap within ptrA, serving as a potential recom-
bination site during transformation. Two round of PCR
were used to generate each fragment. The same strategy
was used for the deletion of Afmpt and Afagt, and primer
pairs used for each deletion are outlined in Supplementary
Table S1. First, each ﬂanking region was ampliﬁed from
A. fumigatus Af293 genomic DNA using primer 1 and
primer 2 for ﬂanking region A, and primer 3 and primer
4 for ﬂanking region B. Subsequent to gel-puriﬁcation, the
fragments were digested with speciﬁc restriction enzymes
(MfeI and HindIII for Afmpt and XmaI and KpnI for
Afagt) to facilitate ligation to ptrA. The ptrA selection
marker was released from plasmid pSK275 (a kind gift
from Professor Sven Krappmann) by digestion with the
enzymes indicated above. For transformation, two
overlapping constructs were ampliﬁed from the ligation
products using primer 5 and ptrA-F for fragment C
(2.6 kb) and primer 6 and ptrA-R for fragment D
(2.2/2.3 kb). Subsequently, A. fumigatus was transformed
with the overlapping fragments C and D. The strategies
used in this study resulted in the complete deletion of
either the Afmpt or Afagt coding region. Transformants
were selected initially on the basis of pyrithiamine resist-
ance. Positive deletion strains were screened by Southern
blot analysis and DIG-hybridization probes were
generated for detection of mutant alleles. Corresponding
abolition of gene expression in deletion strains was
conﬁrmed by RT-PCR.
Engineering of A. fumigatus genes into Saccharomyces
cerevisiae
To introduce Afmpt and Afagt into S. cerevisiae, plasmids
were constructed as follows: the coding regions of Afmpt
and Afagt were ampliﬁed by PCR using primers Afmpt-
PC210 F and Afmpt-PC210 R or Afagt-PC210 F and
Afagt-PC210 R, respectively (Supplementary Table S2).
These primers pairs were designed to incorporate 50
NdeI and 30 SphI restriction sites onto both A. fumigatus
genes for subsequent directional cloning into the pC210
plasmid (39). pC210 contains the SSA1 coding region
under control of the SSA2 promoter that was cloned
into a pRS315 (LEU2) backbone. Following digestion of
pC210 with NdeI and SphI to remove the SSA1 coding
sequence, similarly digested A. fumigatus gene products
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were ligated into pC210 to form pC-Afmpt and pC-Afagt.
The integrity of these plasmids was conﬁrmed by
sequencing. Rich and minimal yeast medium was as
described (40).
Phenotypic assays
Aspergillus fumigatus wild-type and mutant strains were
grown on either AMM agar or MEA agar plates for one
week at 37C. Conidia were harvested aseptically in PBST
[0.1% (v/v) Tween-80] and ﬁltered through sterile
miracloth to remove mycelial matter. Conidia were
counted using a haemocytometer. Conidia (104) were
spotted onto test plates. Plates were incubated at 37C
and colony diameter was measured periodically.
Statistical analysis was carried out using two-way
ANOVA.
Expression and puriﬁcation of Afmpt
The Afmpt gene was obtained by PCR using a suspension
of a single colony of Afmpt-transformed S. cerevisiae (see
above) as a template. PCR was carried out using Phusion
Polymerase (NEB) according to supplier recommenda-
tions with the primers AF forward (50 Phos ATGCATG
TGGTCGATGATTCAAATG) and AF reverse (50 Phos
CTATTGTACTTCGTCTGGCCAAAAG). Cycling con-
ditions comprised an initial cycle of 30 s at 96C, then
25 cycles of 30 s of 96C, 30 s at 60C and 1min at
72C. pMALc2 (NEB) was digested with Xmn1, puriﬁed
and ligation to Xmn1-digested Xmn1 at a 1:1 molar ratio.
The ligation reaction was incubated at room temperature
overnight and then transformed to competent E. coli
DH5a. Plasmids were isolated from resulting colonies
using a miniprep robot (Qiagen 8000) and sequenced on
an ABI3130 16 capillary system. Sequence alignment
revealed one incorrect base (137) and this was corrected
by site-directed PCR mutagenesis using the primer pair
50Phos CGTCTACGCCGTCCTAACG and 50Phos AA
TGTATTGGCCGTTGCATCG.
For protein over-expression and puriﬁcation, a 40 ml
aliquot of colony suspension was inoculated into 10ml
of LB-amp and shaken overnight at 37C. An aliquot
(5ml) of this was then added to 200ml of LB-amp con-
taining glucose (0.2%) and incubated at 37C to an OD595
of approximately 0.6. IPTG (Bioline) was then added to a
ﬁnal concentration of 0.4mM to induce expression and
the cells were harvested after further 3 h incubation by
centrifuging for 20min at 6000 rpm, washing the pellet
with TE pH8 then centrifuging again for 10min at
2800 rpm. Cell-free extracts were prepared by sonication
(Sonicator Ultrasonic Processor XL; Heat Systems)
and centrifugation at 15 000 rpm for 10min at 4C. The
supernatant was applied to an Amylose (NEB) column
(0.8 2.0 cm) that had been equilibrated with 8 column
volumes of binding buffer (20mM Tris–HCl, 200mM
NaCl, 1mM EDTA). The column was then washed with
binding buffer and 2ml fractions were collected until the
protein concentration detected using an ND1000 spectro-
photometer was less than 0.1mg/ml. Aliquots (2ml) of
binding buffer containing 10mM maltose were then
added to elute the protein. The fraction containing the
highest concentration of protein (0.85mg/ml) was stored
in ice and used in subsequent experiments.
Determination of methyltransferase activity
To prepare substrate DNA, 32.6mg of extensively
deproteinized calf thymus DNA (Sigma) was dissolved
in 3ml of 40mM ammediol buffer. [3H]MNU (ARC;
80Ci/mmole; 5mCi in 5ml ethanol:HOAc 99:1) was
transferred to a 50ml conical centrifuge tube and
reduced to 1ml in a stream of air. The DNA solution
was added to this and both DNA and MNU containers
rinsed serially four times with 1ml ammediol buffer and
mixed thoroughly. After 4.5 h at room temperature, the
DNA was precipitated by addition of 1ml 3M NaAc and
24ml ethanol and collected by centrifugation. The super-
natant was carefully removed and stored for disposal and
the DNA was washed extensively with 70% ethanol,
re-dissolved in TE, re-precipitated in ethanol and
washed as above, and ﬁnally dissolved in TE at
3mg/ml. Methyltransferase assays generally used
0.75mg of this DNA which, by assay with recombinant
MGMT and recombinant E. coli MPT and scintillation
counting was calculated to contain 10 fmoles both of
the substrate methylphosphotriester stereoisomer and of
O6-meG. At a counting efﬁciency of 25%, this equated
to 44.4 cpm per fmole of methyl group.
In the methyltransferase assays, increasing volumes of
cell-free extracts, recombinant proteins or extract-
recombinant protein mixtures were incubated with
0.75mg of substrate in a total volume of 300ml made up
with buffer I containing 1mg/ml BSA and incubated for
various times at room temperature or 37C. In the lesion/
inhibitor assays, increasing volumes of extracts were
incubated with protein limiting amounts of recombinant
AfMPT (7 fmoles) or recombinant MGMT (6 fmoles)
for 1 h at room temperature, then substrate DNA added
and incubation continued for 1 h. After incubation, assay
samples were processed as described previously (41) and
radioactivity quantiﬁed by scintillation counting.
RESULTS
Identiﬁcation of candidate A. fumigatus adaptive
response genes
The E. coli Ada protein sequence (NCBI Accession No.
E. coli NP_416717) was used as a query sequence to inter-
rogate the A. fumigatus genome at the CADRE database
(28). A BLASTX search retrieved two signiﬁcant hits for
E. coli Ada with the locus identiﬁers AFUA_5G06350
and AFUA_2G02090. Automatic annotation at CADRE
predicted that these genes encode a DNA repair and tran-
scription factor, and a methylated-DNA–protein-cysteine
methyltransferase, respectively. The E. coli Ada protein
sequence was then aligned with the A. fumigatus protein
sequences using the SIM Alignment Tool at the Swiss
Institute of Bioinformatics (http://www.expasy.ch/tools/
sim-prot.html). The N-terminal domain of Ada preferen-
tially aligned with the putative DNA repair and transcrip-
tion factor (AFUA_5G06350), while the C-terminal
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region of Ada aligned with the A. fumigatus putative
methylated-DNA–protein cysteine methyltransferase
(AFUA_2G02090), making it likely that AFUA_
5G06350 and AFUA_2G0290 perform the MPT and
AGT functions, analogous to the N- and C-terminal
domains of E. coli Ada (6,12). Alignments also revealed
that critical residues for methyl acceptance in E. coli Ada
are also present in A. fumigatus proteins; AfMPT (Cys-38)
and AfAGT (Cys-321), respectively. Protein alignments
are shown in Supplementary Figure S1.
Examination of the upstream regions (300 bp) of the
AFUA_5G06350 and AFUA_2G02090 ORFs identiﬁed
conserved Ada-A and Ada-B boxes, which may represent
potential binding sites for the transcriptional activator
controlling the adaptive response in A. fumigatus
(Supplementary Figure S2). Further BLAST searching
using bacterial sequences of AlkB and AlkA proteins
revealed that there were also homologues in A. fumigatus
encoded by the genes AFUA_6G07990 and AFUA_
4G46800, respectively. Examination of the promoter
regions of these ORFs did not identify Ada-A or Ada-B
conserved sequences (data not shown). Based on all of
these observations, the A. fumigatus genes are now
referred to as AFUA_5G06350 (Afmpt), AFUA_
2G02090 (Afagt), AFUA_4G06800 (AfalkA) and
AFUA_6G07990 (AfalkB).
Identiﬁcation of an adaptive response to alkylating agents
in A. fumigatus
The presence of an adaptive response was investigated
phenotypically by measuring fungal growth inhibition in
the presence of MNNG following overnight incubation
(adaptation) on a sub-lethal dose of MNNG (0.5 mg/ml).
At all MNNG concentrations tested, from 1 mg/ml to
4 mg/ml, an approximate 1.5- to 3-fold increase in fungal
growth was observed following overnight adaptation
compared to the unadapted control (P< 0.001;
Figure 1A).
Expression of the candidate adaptive response genes,
Afmpt, Afagt, AfalkA and AfalkB was investigated follow-
ing exposure to MNNG (0.5 mg/ml) for 30, 60, 120 and
180min. RT-PCR of cDNA synthesized from extracted
RNA indicated that Afmpt and Afagt were up-regulated
at 30 and 60min, respectively, following MNNG addition
and elevated gene expression was maintained for at least
3 h (Figure 1B), while neither AfalkB nor AfalkA gene
expression appeared to be altered (Supplementary
Figure S3).
Disruption of Afmpt and Afagt
Aspergillus fumigatus mpt and agt deletion strains (DAfmpt
and DAfagt) were generated using the bipartite strategy
Figure 1. Aspergillus fumigatus exhibits an adaptive response to alkylating agents. (A) Adaptive response to the alkylating agent MNNG in
A. fumigatus. Overnight exposure of A. fumigatus conidia to MNNG (0.5 mg/ml; adapted), allowed subsequent growth on elevated concentrations
of MNNG (0.5–4mg/ml, P< 0.001) compared to an unadapted control. The radial growths of colonies were measured after 72 h. The mean±stand-
ard error of three experiments is shown. Key: ***P< 0.001. (B) Induction of A. fumigatus mpt and agt upon exposure to MNNG. Expression of
Afmpt or Afagt in the absence () or presence (+) of MNNG over 3 h exposure to MNNG. Lane 1: Time=0, Lanes 2–5: Uninduced T=30, 60, 120
and 180min, Lanes 6–9: Induced T=30, 60, 120 and 180min. calm expression remains unchanged. RNA integrity was determined by the presence of
intact 26S and 18S ribosomal subunits (rRNA).
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(36). Southern blot analysis of genomic DNA from
pyrithiamine-resistant transformants conﬁrmed the dis-
ruption of Afmpt and Afagt (Figure 2). Genomic DNA
from Afmpt transformants was restriction digested with
AfeI. Expected hybridisation patterns were: wild-type
(3951 bp) and DAfmpt (5172 bp). Genomic DNA from
DAfagt transformants was restricted with MfeI.
Expected hybridisation patterns were: wild-type
(3967 bp) and DAfagt (2617 bp). Schematic representa-
tions of Southern blots are shown in Supplementary
Figure S4. Complete replacement of either Afmpt or
Afagt with a pyrithiamine resistance cassette (ptrA) was
conﬁrmed by Southern blot analysis (Figure 2).
DAfmpt and DAfagt are unable to adapt to MNNG
Phenotypic adaptation experiments indicated that the
adaptive response was completely lost upon deletion of
Afmpt (Figure 3A). DAfmpt showed identical growth
rates for all concentrations of MNNG tested regardless
of whether this strain was pre-treated or not with an
inducing dose of MNNG, and these growth rates were
signiﬁcantly lower than growth of the wild-type strain
(P< 0.001; Figure 3A). In fact, the DAfmpt strain was
unable to grow at the highest MNNG concentration
tested (4 mg/ml; Figure 3A). Furthermore, phenotypic
analysis revealed that DAfmpt and DAfagt were more sen-
sitive to MNNG than wild-type at all concentrations
tested when both strains were uninduced (P< 0.001;
Figure 3B). However, neither of the mutants exhibited
increased sensitivity to methyl methanesulphonate
(MMS; data not shown).
Afmpt is essential for the induction of Afagt following
exposure to MNNG
To investigate if the loss of the adaptive response in
DAfmpt coincided with a loss of Afagt gene induction,
we undertook expression analysis and showed that induc-
tion of Afagt by MNNG addition was lost in the Afmpt
deletion strain (Figure 4A). Thus, in contrast to the
pattern of Afagt expression observed in wild-type
cultures exposed to MNNG (Figure 1B), the housekeeping
gene calm and Afagt displayed constitutive transcript
levels when cultures were uninduced or induced
(Figure 4A). In addition, Afmpt gene expression in
DAfagt (Figure 4B) showed a similar pattern to that of
A. fumigatus wild-type (Figure 1B). No changes in gene
expression of AfAlkA or AfAlkB were observed in any of
the strains tested with or without addition of MNNG
(data not shown).
Afagt can fully complement the alkylation sensitivity of
a Saccharomyces cerevisiae mgt1 deletion strain
A S. cerevisiae mgt1 deletion strain (Euroscarf) was engin-
eered to constitutively express Afagt and the resistance of
the resulting transformant to MNNG was determined by
Figure 3. Deletion of Afmpt abolishes the adaptive response and
sensitizes A. fumigatus to MNNG. (A) Deletion of Afmpt leads to
loss of the adaptive response. Following treatment with a sub-lethal
dose of MNNG (0.5 mg/ml), radial growth (mm) of DAfmpt in
increasing concentrations of MNNG (0–4 mg/ml) showed signiﬁcantly
reduced growth compared to wild-type at all concentrations of MMNG
(P< 0.001). Growth was monitored at 72 h. (B) Unadapted DAfmpt and
DAfagt are extremely sensitive to MNNG. DAfmpt and DAfagt display
signiﬁcantly reduced radial growth compared to wild-type on media
containing all concentrations of MNNG tested (0–4 mg/ml; P< 0.001).
Growth was monitored at 72 h. Data in A and B displays the mean of
three independent experiments and the standard error or the mean.
Key ***P< 0.001.
Figure 2. Conﬁrmation of deletion of Afmpt and Afagt in strain Af293.
Identiﬁcation of DAfmpt and DAfmpt by Southern blot analysis.
Expected hybridization patterns were observed as described in
Supplementary Figure S4. M: Molecular weight marker (Roche VII).
WT: Af293 gDNA. DAfmpt candidates; 10, 14: gDNA from two
pyrithiamine resistant Afmpt transformants, T1 and T2. DAfagt candi-
dates; 9, 11, 24: gDNA from three pyrithiamine resistant Afagt
transformants, T1, T2 and T3.
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comparison to an appropriate control strain. Expression
of Afagt in S. cerevisiae mgt1 was able to restore growth
on medium containing high levels of MNNG (Figure 5).
Protection was observed even at concentrations up to
64 mg/ml MNNG, showing that in vivo AfAGT is indeed
a functional orthologue of the Mgt1 protein.
Up-regulation of methyltransferase activities by MNNG
We determined methyltransferase activity by quantifying
the transfer of [3H]-methyl groups from [3H]-
N-methyl-N-nitrosourea-methylated calf thymus DNA to
protein: methyl transfer from O6[3H]meG and
[3H]methylphosphotriesters allowed determination of
AGT and MPT activity, repsectively (see ‘Materials and
Methods’ section and Supplementary Figure S5). In initial
studies, we ﬁrst investigated if the putative AfAGT and
AfMPT activities were quantiﬁable using this assay pro-
cedure. Activity was easily detected in cell-free extracts of
the S. cerevisiae mgt1 deletion that had been transformed
with an expression vector harbouring Afagt but activity in
extracts of Afmpt transformants was close to that of
extracts of vector-transfected controls (Figure 6A).
To conﬁrm that the assay was capable of detecting the
methylphosphotriester (methylPT) demethylation
function of AfMPT, we ligated its ORF into pMALC2,
expressed the fusion protein in E. coli and puriﬁed using
amylose afﬁnity chromatography. The puriﬁed AfMPT
fusion protein (rAfMPT) transferred radioactivity from
substrate DNA to an extent that was closely similar to
that observed for the amino-terminal region of the Ada
MPT protein, that had been expressed and puriﬁed under
identical conditions (Figure 6A). Furthermore, when
rAfMPT was mixed with puriﬁed recombinant human
MGMT, approximately twice as much radioactivity was
transferred to protein, but mixtures of rAfMPT with r
E. coli MPT were not additive (Supplementary Figure
S5) indicating that like the E. coli protein, rAfMPT
acted only on one of the methylPT isomers. We also
found that pre-incubation of the rAfMPT at 37C led to
a rapid loss of activity (t=1/25min) whereas at room
Figure 4. Deletion of Afmpt leads to loss of Afagt induction by MNNG. (A) RT-PCR analysis demonstrates that Afagt mRNA expression is not
up-regulated in DAfmpt following exposure to MNNG, indicating that Afmpt transcriptionally regulates the induction of Afagt. Lane 1: zero time,
Lanes 2 and 3: uninduced () 30min and 120min. Lanes 4–6: induced (+) 30, 120 and 180min. (B) RT–PCR analysis demonstrates that Afmpt
mRNA expression is up-regulated in DAfagt following exposure to MNNG, indicating that Afmpt expression is not dependant on Afagt. Lane 1: zero
time, Lanes 2 and 3: uninduced (–) 30 and 120min. Lanes 4–6: induced (+) 30, 120 and 180min. calm expression remains constant over all
conditions.
Figure 5. Complementation of S. cerevisiae MGT1 deletion by A. fumigatus Afagt. S. cerevisiae expressing Afagt exhibited increased growth
compared to empty vector control following exposure to medium containing MNNG.
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temperature there was very little loss of activity over
40min (Supplementary Figure S5). At room temperature,
methyl transfer to rAfMPT (but not to the E. coli protein)
was complete in approximately 20min (Supplementary
Figure S5). Room temperature incubation was therefore
used for assessing transferase activity in crude extracts of
the A. fumigatus strains.
No [3H]methyltransferase activity was detectable in
cell-free extracts of any of the uninduced A. fumigatus
strains under the assay conditions used. However,
activity was easily detected in extracts of the MNNG-
induced wild-type strain, but not in those of the deletants
(Figure 6B). To investigate the nature of the induced
activity, under substrate-limiting conditions, we added
recombinant AfMPT or human MGMT to the extracts
prior to addition of substrate DNA. This resulted in
higher levels of transferase activity only when rAfMPT
was added to the induced wild-type extract (Figure 6C),
demonstrating that the activity seen was exclusively the
O6-meG repair function, AfAGT. MNNG treatment
thus substantially up-regulates the expression of AfAGT.
The extent of this induction cannot be accurately
calculated because activity was not quantiﬁable in the
pre-MNNG extract under the conditions used, but the
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Figure 6. Up-regulation of methyltransferase activity by MNNG. (A) Methyltransferase activity in extracts of S. cerevisiae transformed with AfMPT
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Nucleic Acids Research, 2012, Vol. 40, No. 16 7813
induced level of activity was calculated to equate to
2.7 103 molecules of AfAGT per cell. Based on the
assay’s lower limit of quantitation of activity, the
uninduced wild-type strain contained less than 30 mol-
ecules of AfAGT per cell, suggesting a 100-fold
induction of expression at the protein level.
Our inability to detect MPT activity in the cell-free
extracts of induced wild-type A. fumigatus might indicate
that the levels of its expression are extremely low, as might
be the case if its function is principally as a signal trans-
duction factor. One of the possible consequences of
this putative low level activity could be increased levels
of persistent methylPT DNA damage from the MNNG
used to induce expression. To examine this, we added
incrementally increasing amounts of the cell-free extracts
of control or induced wild-type or deletant A. fumigatus
to protein-limiting amounts of recombinant AfMPT
(7 fmoles). None of the control extracts had a measur-
able effect on the levels of rAfMPT activity indicating
that there was little or no endogenous methylation
damage in the DNA in the cell-free extracts (Figure 6D).
In contrast, the MNNG-induced DAfmpt cell-free extract
markedly inhibited methyl transfer to rAfMPT, indicating
that high levels of unrepaired methylPT were, as
anticipated, present in the DNA within the extracts. The
inactivation of recombinant AfMPT by extracts of DAfagt
was considerably less, indicating that substantial, but
nevertheless incomplete, repair of methylPT had taken
place in this strain. It is reasonable to conclude that,
in the DAfagt strain, the intact Afmpt gene had been
up-regulated following MNNG treatment, but to an
extent that was insufﬁcient to eliminate all the methylPT
from DNA. This probably explains our inability to detect
AfMPT functional activity in the induced extracts. We
also conﬁrmed our earlier conclusion that Afmpt
up-regulation is not dependent upon the presence of a
functional Afagt gene. While the addition of small
amounts of induced WT extract to rAfMPT had an
additive effect on methyl transfer as a result of the
combined effects of up-regulated AfAGT and the added
rAfMPT (Figure 6C and D), addition of larger volumes
reduced methyl transfer (Figure 6D): again this suggests
that the repair of methylPT was incomplete despite the
up-regulation of AfMPT. These results provide additional
evidence for MNNG-mediated up-regulation of AfMPT,
but also explain why we were unable to detect any increase
in AfMPT activity, in contrast to that for AfAGT.
The eukaryotic adaptive response to alkylating agents is
conﬁned to the Fungal kingdom and is of bacterial origin
Using comparative genomics, we assessed the extent of the
adaptive response in Eukaryotes. We hypothesize that in
order for an organism to potentially possess the adaptive
response to alkylating agents, analogous to what we have
observed in A. fumigatus, it must contain orthologues
of MPT and AGT.
Automated BLAST database searches followed by
manual inspection of homologues showed that the AGT
gene is ubiquitous in the tree of life (Supplementary
Table S1). Where it is absent we expect that other DNA
repair proteins such as alkyltransferase-like proteins may
be present. However, our analysis indicates that MPT is
largely absent from Eukaryotes and where it is present, it
is conﬁned to the Fungal kingdom (Supplementary
Table S1). Closer inspection infers that the potential
adaptive response is actually restricted to members of
the Ascomycota lineage (some of which are major
human or plant pathogens; Figure 7) as they contain a
copy of both MPT and AGT, similar to what is
observed in A. fumigatus.
The origin of the MPT gene in the Ascomycota lineage
is intriguing. There are two competing possibilities. First,
the MPT gene may have arisen in the last common
ancestor (LCA) of the Ascomycete species represented in
our analysis. The Ascomycete MPT was then retained
through multiple speciation events, and at some point
acquired by bacterial species via horizontal gene transfer
(HGT). Alternatively, the MPT gene may be of bacterial
origin and was acquired through HGT from a bacterial
source by the Ascomycete LCA and subsequently retained
during speciation. We tested these hypotheses by recon-
structing a robust maximum likelihood phylogenetic
gene-tree based on clearly identiﬁable MPT orthologues
from the Bacterial and Fungal kingdoms (Figure 8). Our
phylogeny infers that both bacterial and fungal MPTs
form independent, strongly supported (82% bootstrap
support) monophyletic clades (Figure 8). Interestingly,
the vast majority of bacterial species represented in our
analysis belong to the Firmicutes phylum. The Firmicutes
are an ancient bacterial lineage that shared a common
ancestor approximately 2.5 billion years ago (42),
whereas the Ascomycetes are relative newcomers, having
diverged from their Dikarya ancestor approximately
450–968 million years ago (43–45). Due to its distribution
in a wide variety of Firmicutes species, the most parsimo-
nious explanation would suggest an ancient HGT event of
MPT from a Firmicutes ancestor into the LCA of the
Ascomycetes represented in this analysis. The alternative
(unparsimonious) explanation requires multiple independ-
ent HGTs of the Ascomycete MPT gene into different
Firmicutes species.
DISCUSSION
The E. coli Ada protein confers resistance to the biological
effects of alkylating agents through its dual functions as
both a transcriptional activator of the adaptive response
genes (ada, aidB, alkA and alkB), and as a direct repair
protein for the principal toxic and mutagenic lesion,
O6-alkylguanine, generated in DNA by alkylating agents
(14,15). Bioinformatic and protein alignment analysis
revealed ada orthologues in A. fumigatus, referred to
here as Afmpt and Afagt, which encode individual
proteins that resemble the N and C terminal domains of
E. coli Ada, i.e. AfMPT and AfAGT, respectively. Protein
sequence alignment of AfMPT indicated a high level of
sequence conservation with the N-terminal transcriptional
activator domain of E. coli Ada, strongly indicating that
AfMPT could act as a transcriptional activator for the
adaptive response in A. fumigatus. Alignment of AfAGT
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Figure 7. MPT protein maximum likelihood phylogeny. MPT orthologues were sourced from a local database that contained 35 Eukaryote species
in addition to all available Fungal and Bacterial genome data (see ‘Materials and Methods’ section). Bootstrap scores are displayed above branches.
Fungal MPT proteins are found as a strongly supported monophyletic clade (82% bootstrap support). All fungal orthologues are belonging to the
Ascomycetes. Bacterial MPT orthologues also form a monophyletic clade; all bacterial orthologues belong to the Firmicutes phylum, the two
exceptions are Desulfovibrio desulfuricans and Bradyrhizobium japonicum (highlighted) which are both proteobacteria.
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Figure 8. Fungal species phylogeny. Species phylogeny modiﬁed from Medina et al. (2011). The presence or absence of MPT and AGT in each
species is signiﬁed by red (absent) and blue (present) rectangles. AGT is distributed throughout the fungal tree of life. MPT is restricted to the
Ascomycota lineage.
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with E. coli Ada indicates that AfAGT is likely to be a
functional homologue of the C-terminal domain of Ada,
possessing the O6meG and O4meT transferase activities.
This situation is similar to the organization of the adaptive
response operon in B. subtilis, whereby the dual function
of Ada is split into two distinct proteins, AdaA and AdaB
(46). Indeed, based on Ada’s structure, both AfMPT and
AfAGT appeared to possess the critical cysteine residues
for acceptance of the methyl groups. It should also be
noted that A. fumigatus only contains one ORF
encoding an O6-alkyguanine DNA alkyltransferase
(Aafgt). In this article, we show that this gene is clearly
part of an adaptive response to alkylating agents, and
hence we consider that Afagt should be considered as
a true Ada C-terminal domain orthologue rather
than orthologue of the E. coli Ogt, which also acts on
O6meG, but is not up-regulated by MNNG exposure
(47). Although it has been demonstrated that mammalian
O6-methylguanine DNA methyltransferase can be induced
in some cells to provide protection against subsequent
exposure to methylating agents, an adaptive response
similar to that in bacterial cells is clearly absent from
mammalian systems (48).
In this article, we have clearly shown the existence of the
adaptive response in A. fumigatus. Previously, an adaptive
response to MNNG has been reported in A. nidulans (22),
whereby incubation of cell free extracts with radiolabelled
substrate DNA resulted in the detection of four proteins in
gel electrophoresis. These were designated ANAT1-4
(for Aspergillus nidulans AlkylTransferase), three being
predicted as AGTs and one as a MPT (24).
Interrogating the A. nidulans genome identiﬁes only two
ORFs and these clearly encode an AGT and a MPT (G.
W. Jones, unpublished observation). It therefore seems
that two of the original ANAT proteins identiﬁed by
Baker et al. (24) as possessing AGT activity are processed
or modiﬁed versions of a single AGT in this organism.
Thus, the number of repair proteins involved in the
adaptive response to alkylating agents appears to be
conserved between A. fumigatus and A. nidulans, as may
be the overall control of the response.
The adaptive response was further investigated by
examining the mRNA expression levels of Afmpt, Afagt,
AfalkB and AfalkA following exposure to MNNG.
RT-PCR indicated that the expression levels of Afmpt
and Afagt were induced upon exposure to MNNG,
suggesting that Afmpt and Afagt are important in the
adaptive response in A. fumigatus. Induction of Afagt
mRNA was observed after 30min exposure to MNNG
and persisted for at least 3 h, indicating that the induced
expression of Afagt is initiated rapidly following exposure
to MNNG and that this response is persistent for several
hours. Afmpt expression was elevated at 1 h following
addition of MNNG and this was also persistent through-
out the 3 h period investigated in this study. No induction
was observed for AfalkB or AfalkA mRNA upon MNNG
exposure. This lack of induction may reﬂect the absence of
potential Ada box-like transcriptional binding sites
within the upstream promoter regions (300 bp) of
either AfalkA or AfalkB.
Subsequently, the roles of the Afmpt and Afagt encoded
proteins within A. fumigatus were investigated further
using a gene disruption approach. Both genes were indi-
vidually deleted in A. fumigatus Af293 using the bipartite
strategy and a pyrithiamine resistance cassette as a selec-
tion marker, with modiﬁcations (36–38). When tested
for an adaptive response, DAfmpt failed to adapt to
MNNG following induction with a non-lethal dose
when compared to wild-type (P< 0.001). In fact,
DAfmpt displayed almost identical growth rate on
MNNG from 0 mg/ml to 4 mg/ml whether or not it was
induced with MNNG, indicating complete loss of the
adaptive response when Afmpt was absent, and conﬁrming
that adaptation to MNNG is mediated by this protein
within A. fumigatus.
Deletion of either Afmpt or Afagt lead to signiﬁcantly
increased sensitivity to MNNG (0.5–2 mg/ml) when
compared to wild-type (P< 0.001) and no growth was
observed for either strain for the highest concentration
of MNNG tested (4 mg/ml). No differences were
observed between wild-type, DAfmpt or DAfagt regarding
sensitivity to MMS, indicating that AfMPT or AfAGT are
most likely not involved in protection against or repair of
the lethal lesions caused by this alkylating agent. Given
that the primary toxic lesions produced by MMS treat-
ment would be repaired by the AfalkA and AfalkB gene
products, and that these genes are not part of the adaptive
response in A. fumigatus, the lack of sensitivity of the
DAfmpt and DAfagt strains to MMS is not surprising.
Overall, these phenotypic analyses suggest that the roles
of Afmpt and Afagt are speciﬁc in the response to and
protection against speciﬁc alkylation lesions caused by
MNNG, of which the main biologically relevant lesion
is O6meG.
RT-PCR analysis showed no Afagt or Afmpt expression
in DAfagt or DAfmpt, respectively, under non-inducing
conditions, thus validating the gene disruption strategy
used in this study. While Afagt expression was evident in
DAfmpt, there was no difference in the level of expression
between uninduced and induced conditions. This indicates
that Afagt expression was not up-regulated by MNNG in
the DAfmpt mutant strain and hence that Afmpt is essen-
tial for elevated transcription of Afagt by MNNG in
A. fumigatus. This conﬁrms the role of Afmpt as the
fungal equivalent of the E. coli Ada transcriptional
activator in A. fumigatus. Thus, the expression level of
Afmpt was markedly increased in the DAfagt strain
under inducing conditions indicates that Afmpt expression
in response to MNNG is not dependent on the presence of
Afagt but induces it own expression. The presence of the
AdaA and AdaB boxes in the promoter, coupled with the
biochemical data discussed below, certainly support this
hypothesis. At this point, it cannot be excluded that Afmpt
could be affecting the transcription of other gene targets
when Afagt is deleted. However, the vastly increased
sensitivity to MNNG in DAfagt strongly argues that
Afagt is essential for the repair of toxic lesions caused
by MNNG.
The Afagt and Afmpt ORFs were conﬁrmed to encode
active methyltransferase proteins using a functional
in vitro assay of extracts of S. cerevisiae transformed
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with AfAGT or puriﬁed recombinant AfMPT expressed as
an MBP-fusion protein in E. coli. Mixing experiments
indicated that AfMPT demethylates the same methylPT
stereoisomer as does the C-terminal domain of the Ada
protein. The AfMPT was found to be much less stable
than the E. coli equivalent, and to transfer methyl
groups rapidly at room temperature, but no further
characterization was undertaken in this study. The levels
of methyltransferase activities in cell-free extracts of
wild-type, DAfagt and DAfmpt strains were lower than
the lower limit of quantiﬁcation (LOQ) of the assay, sug-
gesting the constitutive expression of about 30 or less mol-
ecules per cell. Adaptive MNNG treatment up-regulated
expression of AfAGT activity at least 100-fold in wild-type
but AfMPT activity remained lower than the LOQ, as did
both functions in the MNNG-treated DAfagt and DAfmpt
strains. That DNA in the DAfagt and wild-type extracts
contained much lower levels of methylPT than the DAfmpt
extract clearly demonstrated that AfMPT expression had
been induced by MNNG in the wild-type and DAfagt
strains. It is reasonable to conclude that AfMPT is
required for the up-regulation of both itself and AfAGT
but that the level of induction of AfMPT is much lower
than that of AfAGT, so that it is completely inactivated
by the levels of damage introduced by MNNG.
Since Baker et al. (24) reported the existence of both
AGT and MPT activities in A. nidulans, no further work
has been reported demonstrating the presence of a MPT in
any eukaryotic organism. We reasoned that if MPTs are
indeed absent from most eukaryotes but can be shown to
exist in pathogenic fungi, there is potential for these DNA
repair proteins to be novel therapeutic targets. We clearly
show that the presence of MPTs in the Eukarya is
conﬁned to the Fungi (Supplementary Table S1). This
absence from non-fungal eukaryotes may be a direct
reﬂection of reliance on other highly efﬁcient ways of
dealing with alkylation damage. The presence of
MGMT in higher eukaryotes will provide protection
from lesions such as O6-meG, while other biologically
relevant lesions may be efﬁciently dealt with through the
action of the mammalian AlkB dioxygenase orthologues,
of which humans have two [for review see Sedgwick (49)].
Within the Fungi the presence of the MPT, and
hence presumably an adaptive response, is restricted to a
number of Ascomycetes (Figure 7). Identifying an
adaptive response and presence of a MPT in A. fumigatus,
as well as predicting the same in pathogenic Fusarium and
Candida species, further highlights this adaptive pathway
as a possible novel therapeutic target. Perhaps the
presence of the adaptive response in these pathogens has
been evolutionary conserved in part as a defence mechan-
ism from host-attack during infection. The apparent
absence of MPT and AGT from some fungi mostly
reﬂects the presence of other proteins capable of dealing
with alkylated DNA lesions, namely the alkyltransferase-
like proteins (ATLs) (16). While it has long been assumed
that the adaptive response to alkylating agents is of
bacterial origin, this has not been formerly proven. Our
comparative genomic and phylogenetic analysis clearly
demonstrates that the MPT (and hence the adaptive
response based upon the MPT) is bacterial in origin and
arose in the Firmicutes phylum (Figure 8). The Firmicutes
species analysed all possess individual copies of MPT and
AGT and we predict that the Ada-type proteins have
arisen through fusion of separate MPT and AGT rather
than vice-versa. The phylogenetic MPT gene-tree
(Figure 8) clearly splits the bacterial and fungal MPTs.
The main conclusion from this tree is that the MPT
arose in the Firmicutes phylum and was transferred via
inter-kingdom HGT to the LCA of the Ascomycete
species analysed in this study. These data represent
the most comprehensive assessment to date of the evolu-
tionary origin of the adaptive response.
In conclusion, this study reports the ﬁrst demonstration
of an adaptive response to alkylating agents in the oppor-
tunistic pathogen A. fumigatus and the genetic and pheno-
typic characterization of the key components. Our
work also clearly deﬁnes the evolutionary history of the
adaptive response. The lack of an equivalent adaptive
response pathway in mammalian cells makes this
pathway an interesting area for further characterization,
as it could prove to be a novel therapeutic drug target in
cases of aspergillosis where immunocompromised individ-
uals are being treated with chemotherapeutic alkylating
agents. In addition, as MPT are not known in man, this
represents a clear distinction between A. fumigatus
and human cells, so, for example, the possibility exists to
develop a prodrug that is activated by AfMPT and should
speciﬁcally sacriﬁce A. fumigatus cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1 and 2 and Supplementary
Figures 1–5.
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